Application of 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas

Magnetic Resonance in Medicine

Volumn 35, Issue 4, 1996, Pages 449-456

  Kuliszkiewicz Janus, Małgorzata ^a   Baczyński, Stanisław ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

31P MRS; Malignant lymphomas; Phospholipid metabolism

Indexed keywords

CHEMOTHERAPY; CHOLESTEROL; DISEASE CONTROL; LIPOPROTEINS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPIDS;

31P-NMR SPECTROSCOPY; HEALTHY VOLUNTEERS; HIGH DENSITY LIPOPROTEIN; LONG-TERM FOLLOW-UP STUDY; LOW DENSITY LIPOPROTEINS; MALIGNANT LYMPHOMAS; SPECTRAL DIFFERENCES; ^31P MRS;

DIAGNOSIS;

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; DIAGNOSTIC AGENT; PHOSPHOLIPID;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LYMPHOMA; MALE; PATIENT MONITORING; PHOSPHOLIPID BLOOD LEVEL; PHOSPHOLIPID METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; REMISSION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; HODGKIN DISEASE; MIDDLE AGED; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HODGKIN DISEASE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 0029658913     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910350402     Document Type: Article

References (32)

1. M. Bental, C. Deutsch, Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn. Reson. Med. 29, 317-326, (1993).
2. 31P NMR studies of phospholipid metabolism. NMR Biomed. 7, 121-127 (1994).
3. J. S. Cohen, R. C. Lyon, P. F. Daly, Monitoring intracellular metabolism by nuclear magnetic resonance. Methods Enzymol. 177, 435-452 (1989).
4. P. R. Cullis, M. J. Hope, B. de Kruijff, A. J. Verkleij, C. P. S. Tilcock, Structural properties and functional roles of phospholipids in biological membranes. Phospholipids Cell Regul. 1-59 (1985).
5. O. Kaplan, J. S. Cohen, Lymphocyte activation and phospholipid pathways. J. Biol. Chem. 266, 3688-3694 (1991).
6. A. C. Kuesel, G. Grashew, W. E. Hull, W. Lorenz, H. W. Thielmann. 31P NMR studies of cultured human tumor cells. Influence of pH on phospholipid metabolite levels and the detection of cytidine 5′-diphosphate choline. NMR Biomed. 3, 78-89 (1990).
7. J. Ruiz-Cabello, J. S. Cohen, Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5, 226-233 (1992).
8. W. Negendank, Studies of human tumors by MRS: a review. NMR Biomed. 5, 303-324 (1992).
9. 31P MRS of experimental tumours. NMR Biomed. 6, 345-365 (1993).
10. 31P NMR spectroscopy. J. Biol. Chem. 262, 14875-14878 (1987).
11. 31P NMR in man and animal models. Ann. NY Acad. Sci. 508, 300-308 (1987).
12. 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Br. J. Cancer 63, 953-958 (1991).
13. S. Bradamante, E. Barchiesi, L. Barenghi, F. Zoppi, An alternative expeditious analysis of phospholipid composition in human blood plasma by 31P NMR spectroscopy. Anal. Biochem. 185, 299-303 (1990).
14. 31P MRS spectra of sera from patients with multiple myeloma. NMR Biomed. 8, 127-132 (1995).
15. M. Kuliszkiewicz-Janus, S. Baczynski, Applications of 31P spectra of sera to chemotherapy monitoring of patients with acute leukemia, in "Proc., SMR, Second Annual Meeting, San Francisco, 1994," p. 1299.
16. T. R. Brown, R. A. Graham, B. S. Szwergold, W. J. Thoma, R. A. Myeyer, Phosphorylated metabolites in tumors, tissues and cell lines. Ann. NY Acad. Sci. 508, 229-240 (1987).
17. D. E. Vance. Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly, Biochem. Cell Biol. 68, 1151-1165 (1990).
18. 31P magnetic resonance phospholipid profiles of neoplastic human breast tissues. Br. J. Cancer 63, 693-698 (1991).
19. F. T. Lindgren, A. V. Nichols, in "The Plasma Proteins" (W. Putnam, Ed.), vol. 2, p. 1. Academic Press, New York, 1961.
20. I. Virgolini, E. Koller, S. Li, Q. Yang, M. Banyai, F. Rauscha, J. Pidlich, W. Pirker, H. Sinzinger, Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia. Atherosclerosis 102, 217-226 (1993).
21. A. J. Mendez, G. M. Anantharamaiah, J. P. Segrest, J. F. Oram. Synthetic amphipathic helical peptides that mimic apolopoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94, 1698-1705 (1994).
22. I. H. Hall, O. T. Wong, R. Simlot, R. A. Izydore, Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro. Res. Commun. Chem. Pathol. Pharmacol. 77, 327-346 (1992).
23. M. Aviram, E. L. Bierman, J. F. Oram, High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J. Lipid Res. 30, 65-76 (1989).
24. V. N. Bochkov, V. A. Tkachuk, Y. S. Kuzmenko, Y. L. Borisova, F. R. Buhler, T. J. Resink, Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol. Pharmacol. 45, 262-270 (1994).
25. K. M. Wasan, M. G. Rosenblum, L. Cheung, G. Lopez-Berestein, Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob. Agents Chemother. 38, 223-227 (1994).
26. T. A. Bani, C. M. Williams, P. S. Boulter, J. W. Dickerson, Plasma lipids and prolactin in patients with breast cancer. Br. J. Cancer. 54, 439-446 (1986).
27. M. L. Knapp, S. al-Sheibani, P. G. Riches, Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors. Clin. Chem, 37, 2093-2101 (1991).
28. M. Barclay, V. P. Skipski, O. Terebus-Kekish, E. M. Greene, R. J. Kaufman, C. C. Stock, Effects of cancer upon high-density and other lipoproteins. Cancer Res. 30, 2420-2430 (1970).
29. S. Umekim, Decreases in serum cholesterol levels in advanced lung cancer. Respiration 60, 178-181 (1993).
30. S. Dessi, B. Batetta, D. Pulisci, O. Spano, R. Cherchi, G. Lanfranco, L. Tessitore, P. Costelli, F. M. Baccino, C. Anchisi, P. Pani, Altered pattern of lipid metabolism in patients with lung cancer. Oncology 49, 436-441 (1992).
31. S. Dessi, B. Batetta, D. Pulisci, O. Spano, C. Anchisi, L. Tessitore, P. Costelli, F. M. Baccino, E. Aroasio, P. Pani. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73, 253-258 (1994).
32. E. Bayerdorffer, G. A. Mannes, W. O. Richter, T. Ochsenkuhn, G. Seeholzer, W. Kopeke, B. Wiebecke, G. Paumgartner, Decreases high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann. Intern. Med. 118, 481-487 (1993).